LCIP
RMD icon

Life Cycle Investment Partners’s ResMed RMD Stock Holding History

Life Cycle Investment Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.8M Buy
255,432
+47,389
+23% +$9.82M 0.23% 86
2026
Q1 		$46.7M Buy
208,043
+78,390
+60% +$19.5M 0.3% 78
2025
Q4 		$31.2M Buy
+129,653
New +$33.2M 0.22% 78

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Life Cycle Investment Partners's RMD Position: Q2 2026 in Review

Life Cycle Investment Partners increased its ResMed (RMD) stake by 23% in Q2 2026, buying an estimated $9.82M and bringing the position to 255,432 shares worth $49.8M. The position accounts for 0.23% of the portfolio, ranked #86.

Life Cycle Investment Partners first reported a position in RMD in Q4 2025 and has held it in 3 quarters since. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Life Cycle Investment Partners held 255,432 shares of ResMed worth $49.8M as of Q2 2026.
  • Life Cycle Investment Partners bought 47,389 ResMed shares in Q2 2026, an estimated $9.82M.
  • ResMed made up 0.23% of Life Cycle Investment Partners's portfolio in Q2 2026, its #86 holding.
  • Life Cycle Investment Partners first reported a position in ResMed in Q4 2025 and has held it in 3 quarters since.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Life Cycle Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.